Replies to post #535853 on NorthWest Biotherapeutics Inc (NWBO)

[CrashOverride]

They will need $40B and shares or a lot more cash. Linda isn't selling for $40B.

Trodelvy was $21B. We have a platform that targets all antigens and neoantigens as well as Fordist manufacturing process that brings economies of scale.

[Horseb4CarT]

Although it’s not exactly the same initial targeting, I’m a little cautious about the collaboration announced by Merck with Moderna, using a Moderna rdna vaccine in conjunction with Keytruda in an allogeneic approach (I think first for breast cancer?)

Maybe Merck can afford this as well as well as Murcidencel?